Table 2. Baseline characteristics.
| Author | Age | Female (%) | Diabetes mellitus (%) | Atrial fibrillation (%) | Pacemaker | LVEF (%) | Log EuroSCORE II | Prior cardiac surgery (%) | Mild TR (I) (%) | Moderate TR (II) (%) | Severe TR (III/IV) (%) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | Flexible | Rigid | |||||||||||
| Gatti | 69.2±9.3 | 69.3±10.2 | 52.2 | 52.1 | 5.5b | 4.3b | 31.9 | 25.6 | 1.2 | 0.9 | 55.2±12.3 | 56.4±12.4 | 9.2±10.8 | 12±13.4 | 11.6 | 15.4 | 31.6 | 22.2 | 44.3 | 51.3 | 24.1 | 26.5 | ||||||||||
| Izutani | 72.6±11 | 72.4±10 | 51.4 | 64.6 | NA | NA | 85.7 | 72.0 | NA | NA | 56.0±8.0 | 57.5±13 | NA | NA | NA | NA | 0.0 | 7.3 | 28.6 | 30.5 | 71.4 | 62.2 | ||||||||||
| Naviaa | 68±12 | 60.4 | 20.0 | 68.0 | 15.9 | 47±14 | NA | NA | 48.0 | 2.2 | 13.0 | 83.0 | ||||||||||||||||||||
| Pfannmuller | 68.5±10.2 | 69.8±8.8 | 54.7 | 56.0 | 25.5 | 36.0 | 63.4 | 58.5 | 17.1 | 10.6 | 58.3±15.7 | 56.3±15.8 | 12.9±12.3 | 13.7±12.8 | 22.2 | 21.5 | 17.1 | 13.8 | 55.7 | 54.9 | 27.1 | 30.5 | ||||||||||
| Wang | 56±5.2 | 58±4.8 | 58.7 | 48.3 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.0 | 0.0 | 16.7 | 18.3 | 83.3 | 81.7 | ||||||||||
a, study only reported demographics for entire group; b, on insulin; MV, mitral valve; AV, atrial valve; ASD, atrial septal defect; TR, tricuspid regurgitation; OS, observational study; LVEF, left ventricular ejection fraction; NA, not available.